Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229–263

PubMed  Google Scholar 

Curigliano G, Burstein HJ, Winer EP et al (2017) De-escalating and escalating treatments for early-stage breast cancer: the St. gallen international expert consensus conference on the primary therapy of early breast cancer 2017. Ann Oncol 28:1700-1712

Liao XZ, Shi JF, Liu JS et al (2018) Medical and non-medical expenditure for breast cancer diagnosis and treatment in China: a multicenter cross-sectional study. Asia Pac J Clin Oncol 14:167–178

Article  PubMed  Google Scholar 

Zafar SY, Abernethy AP (2013) Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park) 27:80-1, 149

Ehsan AN, Wu CA, Minasian A et al (2023) Financial toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2022.55388

Article  PubMed  PubMed Central  Google Scholar 

Carrera PM, Curigliano G, Santini D et al (2024) ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer. ESMO Open 9:102992

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bhoo-Pathy N, Ng CW, Lim GC et al (2019) Financial toxicity after cancer in a setting with universal health coverage: a call for urgent action. J Oncol Pract 15:e537–e546

Article  PubMed  Google Scholar 

Jing JF, Feng R, Zhang XJ et al (2020) Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China. Breast Cancer Res Treat 181:435–443

Article  PubMed  Google Scholar 

Lentz R, Benson AB 3rd, Kircher S (2019) Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies. J Surg Oncol 120:85–92

Article  PubMed  Google Scholar 

Smith GL, Lopez-Olivo MA, Advani PG et al (2019) Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Canc Netw 17:1184–1192

Article  PubMed  PubMed Central  Google Scholar 

Asaad M, Boukovalas S, Chu CK et al (2020) Financial toxicity and contralateral prophylactic mastectomy: an analysis using propensity score methods. Breast Cancer Res Treat 183:649–659

Article  PubMed  Google Scholar 

Kumar NG, Berlin NL, Hawley ST et al (2022) Financial toxicity in breast reconstruction: a national survey of women who have undergone breast reconstruction after mastectomy. Ann Surg Oncol 29:535–544

Article  Google Scholar 

Yusuf M, Pan J, Rai SN et al (2022) Financial toxicity in women with breast cancer receiving radiation therapy: final results of a prospective observational study. Pract Radiat Oncol 12:e79–e89

Article  PubMed  Google Scholar 

Chan RJ, Gordon LG, Tan CJ et al (2019) Relationships between financial toxicity and symptom burden in cancer survivors: a systematic review. J Pain Symptom Manage 57:646

Article  PubMed  Google Scholar 

Perni S, Azoba C, Gorton E et al (2022) Financial toxicity, symptom burden, illness perceptions, and communication confidence in cancer clinical trial participants. JCO Oncol Pract 18:e1427–e1437

Article  PubMed  Google Scholar 

Yuan XY, Sun YL, Kuang Y et al (2022) Status and influencing factors of cancer-related financial toxicity of breast cancer survivors. Chinese Nursing Management 22:830–835

Google Scholar 

Chan RJ, Cooper B, Koczwara B et al (2022) Characteristics associated with inter-individual variability in financial distress in patients with breast cancer prior to and for 12 months following surgery. Support Care Cancer 30:1293–1302

PubMed  Google Scholar 

Chan RJ, Gordon L, Zafar SY et al (2018) Financial toxicity and symptom burden: what is the big deal? Support Care Cancer 26:1357–1359

PubMed  Google Scholar 

Zhang WR, Li YB, Li LF et al (2023) Vicious cycle of emotion regulation and ODD symptoms among Chinese school-age children with ODD: a random intercept cross-lagged panel model. Child Adolesc Psychiatry Ment Health. https://doi.org/10.1186/s13034-023-00579-x

Article  PubMed  PubMed Central  Google Scholar 

Scott PW (2021) Accounting for time-varying inter-individual differences in trajectories when assessing cross-lagged models. Struct Equ Modeling-Multidiscip J 28:365–375

Article  Google Scholar 

Hamaker EL, Kuiper RM, Grasman RP (2015) A critique of the cross-lagged panel model. Psychol Methods 20:102–16

Article  PubMed  Google Scholar 

Curran PJ, Howard AL, Bainter SA et al (2014) The separation of between-person and within-person components of individual change over time: a latent curve model with structured residuals. J Consult Clin Psychol 82:879–894

Article  PubMed  Google Scholar 

von Elm E, Altman DG, Egger M et al (2014) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12:1495–1499

Article  Google Scholar 

de Souza JA, Yap BJ, Wroblewski K et al (2017) Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive score for financial Toxicity (COST). Cancer 123:476–484

Article  PubMed  Google Scholar 

Yu HH, Bi X, Liu YY (2017) Reliability and validity of the Chinese version on Comprehensive Scores for Financial Toxicity based on the patient-reported outcome measures. Chin J Epidemiol 38:1118–1120

CAS  Google Scholar 

Kuang Y, Jing F, Tang LC et al (2024) Translation and validation of the Chinese version of the BCPT eight symptom scale (BESS) in patients with breast cancer. Asia-Pac J Oncol Nurs. https://doi.org/10.1016/j.apjon.2024.100449

Article  PubMed  PubMed Central  Google Scholar 

Cella D, Land SR, Chang CH et al (2008) Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women. Breast Cancer Res Treat 109:515–526

Article  PubMed  Google Scholar 

Fu L, Hu Y, Lu ZQ et al (2018) Validation of the simplified Chinese version of the Memorial Symptom Assessment Scale-Short Form among cancer patients. J Pain Symptom Manage 56:113–121

Article  PubMed  Google Scholar 

Larn WWT, Law CC, Fu YT et al (2008) New Insights in symptom assessment: the Chinese versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS). Journal of Pain and Symptom Management 36:584–595

Article  Google Scholar 

Webber K, Davies AN (2011) Validity of the memorial symptom assessment scale-short form psychological subscales in advanced cancer patients. J Pain Symptom Manage 42:761–767

Article  PubMed  Google Scholar 

Kuang Y, Qiu J, Liu Y et al (2025) Trajectories and predictors of financial toxicity in breast cancer patients: a multicenter longitudinal study in China. Breast 81:104441

Article  PubMed  PubMed Central  Google Scholar 

Ngan TT, Minh HV, Donnelly M et al (2021) Financial toxicity due to breast cancer treatment in low- and middle-income countries: evidence from Vietnam. Support Care Cancer 29:6325–6333

PubMed  PubMed Central  Google Scholar 

Shim S, Kang D, Kim N et al (2022) Validation of Korean version of the comprehensive score for financial toxicity (COST) among breast cancer survivors. Cancer Res Treat 54:834–841

Article  PubMed  Google Scholar 

Politi MC, Yen RW, Elwyn G et al (2021) Women who are young, non-White, and with lower socioeconomic status report higher financial toxicity up to 1 year after breast cancer surgery: a mixed-effects regression analysis. Oncologist 26:e142–e152

Article  PubMed  Google Scholar 

Benedict C, Fisher S, Schapira L et al (2022) Greater financial toxicity relates to greater distress and worse quality of life among breast and gynecologic cancer survivors. Psycho-Oncol 31:9–20

Article  Google Scholar 

Corkum J, Zhu VC, Agbafe V et al (2022) Area deprivation index and rurality in relation to financial toxicity among breast cancer surgical patients: retrospective cross-sectional study of geospatial differences in risk profiles. J Am Coll Surg 234:816–826

Article  PubMed  Google Scholar 

Smith GL, Smith BD, Wu CF et al (2024) Financial toxicity in breast cancer patients receiving regional nodal irradiation: variation by cancer subtype. Breast 78:103813

Article  PubMed  PubMed Central  Google Scholar 

Jacob C (2013) Statistical power analysis for the behavioral sciences, 2nd edn. Taylor and Francis. https://doi.org/10.4324/9780203771587

Musca SC, Kamiejski R, Nugier A et al (2011) Data with hierarchical structure: impact of intraclass correlation and sample size on type-I error. Front Psychol 2:74